Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:21:25.718Z.
Calculation as of: 2026-10-06T16:21:25.718Z.
Quote observation: 2026-10-06T16:04:32.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f9d3bab38235a1653807ee573cee89b2588007a5210257548b702658f8274e90
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
BioRestorative Therapies, Inc.
Market Cap
$3.07M
Free Cash Flow Yield
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD |
|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | $3.07M | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $3.04M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.18M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.17M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.97M | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.28M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.46M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.48M | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
